Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols

Scand Cardiovasc J. 2024 Dec;58(1):2343383. doi: 10.1080/14017431.2024.2343383. Epub 2024 May 2.NO ABSTRACTPMID:38695202 | DOI:10.1080/14017431.2024.2343383

Source: Scandinavian Cardiovascular Journal - May 2, 2024 Category: Cardiology Authors: Bj örn Redfors Source Type: research